Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Tom Butler & John G Gribben. (2008) Biologic prognostic markers and their application in clinical trials and management of chronic lymphocytic leukaemia patients. Expert Opinion on Medical Diagnostics 2:1, pages 101-112.
Read now
Read now
Peter Apelgren, Sverker Hasselblom, Olle Werlenius, Herman Nilsson-Ehle, Per-Ola Andersson & On Behalf Of The Western Sweden Lymphoma Group. (2006) Evaluation of clinical staging in chronic lymphocytic leukemia- population-based study. Leukemia & Lymphoma 47:12, pages 2505-2516.
Read now
Read now
Stefano Molica. (2006) Sex differences in incidence and outcome of chronic lymphocytic leukemia patients. Leukemia & Lymphoma 47:8, pages 1477-1480.
Read now
Read now
S. Molica. (2005) Quality of life in chronic lymphocytic leukemia: A neglected issue. Leukemia & Lymphoma 46:12, pages 1709-1714.
Read now
Read now
Articles from other publishers (14)
Zekhethelo A. Mkhwanazi, Tawanda M. Nyambuya, Snenhlanhla A. Mfusi & Bongani B. Nkambule. (2022) Prognostic markers in patients with chronic lymphocytic leukaemia on targeted therapy, chemoimmunotherapy with anti-CD20 monoclonal antibody: a systematic review and meta-analysis of prognostic factors. BMC Cancer 22:1.
Crossref
Crossref
Neda Alrawashdh, Joann Sweasy, Brian Erstad, Ali McBride, Daniel O. Persky & Ivo Abraham. (2021) Survival trends in chronic lymphocytic leukemia across treatment eras: US SEER database analysis (1985–2017). Annals of Hematology 100:10, pages 2501-2512.
Crossref
Crossref
Nina Kreuzberger, Johanna AAG Damen, Marialena Trivella, Lise J Estcourt, Angela Aldin, Lisa Umlauff, Maria DLA Vazquez-Montes, Robert Wolff, Karel GM Moons, Ina Monsef, Farid Foroutan, Karl-Anton Kreuzer & Nicole Skoetz. (2020) Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis. Cochrane Database of Systematic Reviews 2020:7.
Crossref
Crossref
Carolina Muñoz-Novas, María Poza-Santaella, Isabel González-Gascón y Marín, María Hernández-Sánchez, Ana-Eugenia Rodríguez-Vicente, María-Stefania Infante, Cecilia Heras, María-Ángeles Foncillas, Karen Marín, Jesús-María Hernández-Rivas & José-Ángel Hernández. (2018) The International Prognostic Index for Patients with Chronic Lymphocytic Leukemia Has the Higher Value in Predicting Overall Outcome Compared with the Barcelona-Brno Biomarkers Only Prognostic Model and the MD Anderson Cancer Center Prognostic Index. BioMed Research International 2018, pages 1-8.
Crossref
Crossref
Abibatou Sall, Awa Oumar Touré, Fatimata Bintou Sall, Moussa Ndour, Seynabou Fall, Abdoulaye Sène, Blaise Félix Faye, Moussa Seck, Macoura Gadji, Tandakha Ndiaye Dièye, Claire Mathiot, Sophie Reynaud, Saliou Diop & Martine Raphaël. (2016) Characteristics of chronic lymphocytic leukemia in Senegal. BMC Hematology 16:1.
Crossref
Crossref
Stefano Molica, Diana Giannarelli, Massimo Gentile, Giovanna Cutrona, Nicola Di Renzo, Francesco Di Raimondo, Antonino Neri, Massimo Federico, Manlio Ferrrarini & Fortunato Morabito. (2012) External validation on a prospective basis of a nomogram for predicting the time to first treatment in patients with chronic lymphocytic leukemia. Cancer 119:6, pages 1177-1185.
Crossref
Crossref
William G. WierdaSusan O'BrienXuemei WangStefan FaderlAlessandra FerrajoliKim-Anh DoGuillermo Garcia-ManeroJorge CortesDeborah ThomasCharles A. KollerJan A. BurgerSusan LernerEllen SchletteLynne AbruzzoHagop M. KantarjianMichael J. Keating. (2011) Multivariable Model for Time to First Treatment in Patients With Chronic Lymphocytic Leukemia. Journal of Clinical Oncology 29:31, pages 4088-4095.
Crossref
Crossref
Susan Mallett, Patrick Royston, Rachel Waters, Susan Dutton & Douglas G Altman. (2010) Reporting performance of prognostic models in cancer: a review. BMC Medicine 8:1.
Crossref
Crossref
Susan Mallett, Patrick Royston, Susan Dutton, Rachel Waters & Douglas G Altman. (2010) Reporting methods in studies developing prognostic models in cancer: a review. BMC Medicine 8:1.
Crossref
Crossref
Huei-Ting TsaiNeil E. CaporasoRobert A. KyleJerry A. KatzmannAngela DispenzieriRichard B. HayesGerald E. MartiMaher AlbitarPaolo Ghia, S. Vincent Rajkumar & Ola Landgren. (2009) Evidence of serum immunoglobulin abnormalities up to 9.8 years before diagnosis of chronic lymphocytic leukemia: a prospective study. Blood 114:24, pages 4928-4932.
Crossref
Crossref
Ana Pilar González Rodríguez, Esther González García, Carmen Fernández Álvarez, Ana Julia González Huerta & Segundo González Rodríguez. (2009) Estudio epidemiológico y comparación de los índices pronósticos del MD Anderson Cancer Center y el índice del Gruppo Italiano Malattie Ematologiche Maligne dell′ Adulto en pacientes con leucemia linfática crónica de células B. Medicina Clínica 133:5, pages 161-166.
Crossref
Crossref
Beate Klimm & Andreas Engert. (2008) Differences in hematotoxicity between male and female patients with Hodgkin lymphoma and other malignancies. Nature Clinical Practice Oncology 5:6, pages 316-323.
Crossref
Crossref
Versha Banerji, James B. Johnston & Matthew D. Seftel. (2007) The role of hematopoietic stem cell transplantation in Chronic Lymphocytic Leukemia. Transfusion and Apheresis Science 37:1, pages 57-62.
Crossref
Crossref
. (2005) Current Awareness in Hematological Oncology. Hematological Oncology 23:2, pages 82-89.
Crossref
Crossref